Target intelligence / Profile preview

G protein-coupled receptor-mediated calcium signaling pathway (GPCR-Ca2+ signaling)

Target
GPCR-Ca2+ signaling
Molecular classification
Pathway, Signal transduction
01

Overview

G protein-coupled receptor (GPCR)-mediated calcium signaling is a fundamental mechanism by which cells respond to external stimuli such as hormones and neurotransmitters (StatPearls, 2023). This pathway typically involves the activation of Gq-type heterotrimeric G proteins, which in turn stimulate the enzyme phospholipase C (PLC) (Nature, 2020). PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (UniProt). IP3 diffuses through the cytosol to bind to IP3 receptors on the endoplasmic reticulum, causing a rapid release of stored calcium ions into the cytoplasm (PubMed, 2012). This increase in intracellular calcium regulates a wide array of physiological processes, including muscle contraction, neurotransmitter release, and gene transcription (NIH). Dysregulation of this pathway is implicated in numerous pathologies, including hypertension, heart failure, and various cancers (NCBI, 2014). Consequently, the individual receptors and enzymes within this pathway are frequent targets for pharmacological intervention, such as angiotensin II receptor blockers and muscarinic agonists (PubChem).

Other names
GPCR-mediated calcium signalingGq protein-coupled signalingPhosphoinositide signaling pathwayCalcium-mediated signal transduction
02

Mechanism of action

Activation of Gq-coupled receptors leads to Phospholipase C (PLC) activation, which hydrolyzes PIP2 into IP3 and DAG. IP3 then binds to receptors on the endoplasmic reticulum to trigger the release of intracellular calcium ions.

03

Biological functions

Signal transductionCalcium homeostasisMuscle contractionNeurotransmissionCell proliferationGene expression
04

Disease associations

Cardiovascular diseaseCancerNeurodegenerative diseaseInflammationEndocrine disorders
05

Safety considerations

Ubiquity of calcium signaling leading to pleiotropic side effectsPotential for cardiac arrhythmiasDisruption of normal cellular homeostasisOff-target effects on non-target tissues
06

Interacting drugs

Losartan

6 more in the full profile.

07

Biomarkers

Intracellular calcium concentrationInositol trisphosphate (IP3) levelsDiacylglycerol (DAG) levelsProtein kinase C (PKC) activity

Beyond the preview

Go deeper on G protein-coupled receptor-mediated calcium signaling pathway (GPCR-Ca2+ signaling).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor-mediated calcium signaling pathway (GPCR-Ca2+ signaling).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call